GlassScriptPhysician profile
Bryan P Aduddell
NPI 1437598877
$4,356.14
in general payments reported to CMS, 2019-2025
14 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $149 · 2021: $789 · 2022: $615 · 2023: $298 · 2024: $1,889 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,301 · Food and Beverage: $1,023.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,300.84 |
| Food and Beverage | $1,022.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $1,736.38 | 2024 | Evoke |
| Boston Scientific Corporation | $826.27 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $732.55 | 2021-2024 | Intellis Adaptivestim |
| Nevro Corp. | $321.42 | 2022-2024 | Senza |
| Abbott Laboratories | $269.81 | 2019-2025 | Eterna, Proclaim |
| Vertos Medical, INC. | $141.84 | 2022 | |
| Medtronic USA, INC. | $121.01 | 2020 | |
| Globus Medical, INC. | $49.15 | 2025 | Senza, Vyrsa V1 |
| Vision Quest Industries INC. | $49.10 | 2022 | |
| Scilex Pharmaceuticals INC. | $47.93 | 2023-2024 | Ztlido |
| Fidia Pharma USA INC. | $18.57 | 2023 | Triluron, Hymovis |
| Forte Bio-Pharma LLC | $15.14 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $13.84 | 2019 | |
| Allergan, INC. | $13.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Aduddell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.